Last reviewed · How we verify
NCT04251897
Novel Support Surface to Alleviate Pressure Ulcer
NA trial testing Novel support surface in Immobility Syndrome in 10 participants. Completed in 30 August 2021.
30 August 2021
Quick facts
| Lead sponsor | Tan Tock Seng Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 10 |
| Start date | 2 September 2020 |
| Primary completion | 30 August 2021 |
| Estimated completion | 30 August 2021 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Novel support surface
Conditions studied
- Immobility Syndrome — all drugs for Immobility Syndrome →
- Pressure Ulcer — all drugs for Pressure Ulcer →
- Pressure Injury — all drugs for Pressure Injury →
Sponsor
Tan Tock Seng Hospital
Who can join
Adults 21 to 85, any sex, with Immobility Syndrome or Pressure Ulcer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prototype support surface has been designed which aims to successfully redistributes the pressures exerted and provides sufficient support to human soft tissue We want to prove the effectiveness of the prototype support surface by enlisting patients in a clinical trial, where we will assess the presence of pressure ulcers, and the ability of the patients to tolerate the support surface, and also measure the pressure over time and compare them to when the patients are using standard mattresses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04251897
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Immobility Syndrome
Currently open trials in the same condition.
- NCT04199923 — Mechanisms of Disuse Atrophy in Human Skeletal Muscle (iMOB) · NA · active not recruiting
Other Tan Tock Seng Hospital trials
Trials by the same sponsor.
- NCT07078240 — Examining Nurses' Trust and Acceptance of FAIR, an AI-powered Falls Risk Recommender · NA · not yet recruiting
- NCT07257341 — Pilot Study of Normative Range of Field of Binocular Single Vision in Adults in Singapore · recruiting
- NCT07151729 — Use of Anodal tDCS to Enhance Upper Limb Recovery in Stroke · NA · recruiting
- NCT07122752 — Feasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy · active not recruiting
- NCT07255859 — CRYSTALSIGHT Cohort 2.0 · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04251897 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tan Tock Seng Hospital
- Last refreshed: 28 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04251897.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing